17-alpha-Hydroxyprogesterone
The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Isotretinoin.
All-Trans-Retinol
The risk or severity of adverse effects can be increased when Vitamin A is combined with Isotretinoin.
Chlortetracycline
The risk or severity of adverse effects can be increased when Chlortetracycline is combined with Isotretinoin.
Advertisement
Cyproterone Acetate
The therapeutic efficacy of Cyproterone acetate can be decreased when used in combination with Isotretinoin.
Demeclocycline
The risk or severity of adverse effects can be increased when Demeclocycline is combined with Isotretinoin.
Desogestrel
The therapeutic efficacy of Desogestrel can be decreased when used in combination with Isotretinoin.
Advertisement
Dienogest
The therapeutic efficacy of Dienogest can be decreased when used in combination with Isotretinoin.
Diethylstilbestrol
The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Isotretinoin.
Doxycycline
The risk or severity of adverse effects can be increased when Doxycycline is combined with Isotretinoin.
Advertisement
Doxycycline Anhydrous
The risk or severity of adverse effects can be increased when Doxycycline is combined with Isotretinoin.
Drospirenone
The therapeutic efficacy of Drospirenone can be decreased when used in combination with Isotretinoin.
Estradiol
The therapeutic efficacy of Estradiol can be decreased when used in combination with Isotretinoin.
Estradiol Cypionate
The therapeutic efficacy of Estradiol cypionate can be decreased when used in combination with Isotretinoin.
Estradiol Valerate
The therapeutic efficacy of Estradiol valerate can be decreased when used in combination with Isotretinoin.
Ethanol
The risk or severity of adverse effects can be increased when Ethanol is combined with Isotretinoin.
Ethinyl Estradiol
The therapeutic efficacy of Ethinyl Estradiol can be decreased when used in combination with Isotretinoin.
Ethynodiol Diacetate
The therapeutic efficacy of Ethynodiol diacetate can be decreased when used in combination with Isotretinoin.
Etonogestrel
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Isotretinoin.
Gestodene
The therapeutic efficacy of Gestodene can be decreased when used in combination with Isotretinoin.
Gestrinone
The therapeutic efficacy of Gestrinone can be decreased when used in combination with Isotretinoin.
hydroxyprogesterone caproate (USP)
The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Isotretinoin.
Levonorgestrel
The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Isotretinoin.
Lynestrenol
The therapeutic efficacy of Lynestrenol can be decreased when used in combination with Isotretinoin.
Medroxyprogesterone Acetate
The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Isotretinoin.
Megestrol Acetate
The therapeutic efficacy of Megestrol acetate can be decreased when used in combination with Isotretinoin.
Mestranol
The therapeutic efficacy of Mestranol can be decreased when used in combination with Isotretinoin.
Minocycline
The risk or severity of adverse effects can be increased when Minocycline is combined with Isotretinoin.
Mipomersen
Isotretinoin may increase the hepatotoxic activities of Mipomersen.
Nomegestrol Acetate
The therapeutic efficacy of Nomegestrol acetate can be decreased when used in combination with Isotretinoin.
Norelgestromin
The therapeutic efficacy of Norelgestromin can be decreased when used in combination with Isotretinoin.
Norethindrone
The therapeutic efficacy of Norethisterone can be decreased when used in combination with Isotretinoin.
Norethynodrel
The therapeutic efficacy of Norethynodrel can be decreased when used in combination with Isotretinoin.
Norgestimate
The therapeutic efficacy of Norgestimate can be decreased when used in combination with Isotretinoin.
Norgestrel
The therapeutic efficacy of Norgestrel can be decreased when used in combination with Isotretinoin.
Oxytetracycline
The risk or severity of adverse effects can be increased when Oxytetracycline is combined with Isotretinoin.
Oxytetracycline Anhydrous
The risk or severity of adverse effects can be increased when Oxytetracycline is combined with Isotretinoin.
Tetracycline
The risk or severity of adverse effects can be increased when Tetracycline is combined with Isotretinoin.
Ulipristal
The therapeutic efficacy of Ulipristal can be decreased when used in combination with Isotretinoin.
